Pipeline — registered trials by phase
Donor After Circulatory Death Heart CAP Trial
— · Heart Transplant · Completed · est. 2021-12-21
US National OCS Liver Perfusion (OLP) Registry
— · Liver Transplant · Recruiting · est. 2031-10
International EXPAND Heart Pivotal Trial
— · Heart Transplant · Completed · est. 2018-04-25
Heart EXPAND Continued Access Protocol
— · Heart Transplant · Completed · est. 2021-09-15
INSPIRE Continuation Post-Approval Study
— · Bronchiolitis Obliterans · Completed · est. 2021-10-12
OCS Liver PROTECT Continued Access Protocol
— · Liver Transplant · Completed · est. 2021-02-02
OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
— · OCS Lung System · Completed · est. 2021-09-30
OCS Liver Perfusion (OLP) Post-Approval Registry
— · Liver Transplant · Active Not Recruiting · est. 2024-03-22
OCS Heart EXPAND + CAP Continued Follow-Up
— · Heart Transplant · Active Not Recruiting · est. 2026-08
OCS Liver PROTECT Continuation Post-Approval Study
— · Liver Transplant · Completed · est. 2021-11-05
International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation
— · Lung Preservation · Completed · est. 2014-09
Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation
— · Heart Failure · Completed · est. 2013-10
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
— · Lung Transplantation · Active Not Recruiting · est. 2025-11-30
OCS Heart Perfusion Post-Approval Registry
— · Transplant · Active Not Recruiting · est. 2025-12
Enhancing Heart Allograft Function With the OCS Heart System Trial
— · Heart Transplant · Recruiting · est. 2027-01-30
US National OCS Heart Perfusion (OHP) Registry
— · Heart Transplant · Recruiting · est. 2029-08-31
OCS DCD Heart + CAP Continued Follow-Up
— · Heart Transplant · Active Not Recruiting · est. 2026-10
Decreasing Edema With a Novel OCS Solution Trial
— · Lung Transplant · Not Yet Recruiting · est. 2027-12
International EXPAND Lung Pivotal Trial
— · Lung Transplant · Completed · est. 2016-11-22
OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation
— · Liver Transplantation, Liver Preservation for Transplant · Completed · est. 2019-10-22
Donors After Circulatory Death Heart Trial
— · Heart Transplant · Completed · est. 2021-04-01
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study
— · Liver Transplant · Completed · est. 2023-02-02
Trial of the TransMedics Organ Care System™ Liver For Preserving and Assessing Donor Livers for Transplantation
— · Liver Preservation · Completed · est. 2017-09-19
US National TOP Registry
— · Lung Transplant · Recruiting · est. 2034-11
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where TransMedics is lead sponsor; 24 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-10Current report (material event)
- 10-Q2026-08-04Quarterly report
- 8-K2026-08-04Current report (material event)
- SD2026-05-29SD
- 8-K2026-05-21Current report (material event)
- DEFA14A2026-05-07DEFA14A
- 10-Q2026-05-05Quarterly report
- 8-K2026-05-05Current report (material event)
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- ARS2026-04-10Annual report to holders
- DEFA14A2026-04-10DEFA14A
- DEF 14A2026-04-10Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-02-27Current report (material event)
- 10-K2026-02-24Annual report
- 8-K2026-02-24Current report (material event)
- 8-K2026-02-04Current report (material event)
- 8-K2026-01-12Current report (material event)
- 10-Q2025-10-29Quarterly report
- 8-K2025-10-29Current report (material event)
- 8-K2025-10-06Current report (material event)
- 10-Q2025-07-30Quarterly report
- 8-K2025-07-30Current report (material event)
- SCHEDULE 13G/A2025-07-18SCHEDULE 13G/A
- SD2025-05-30SD
- 8-K2025-05-23Current report (material event)
- SCHEDULE 13G/A2025-05-12SCHEDULE 13G/A
- 10-Q2025-05-08Quarterly report
- 8-K2025-05-08Current report (material event)
- ARS2025-04-10Annual report to holders
- DEFA14A2025-04-10DEFA14A
- DEF 14A2025-04-10Proxy statement
- 10-K2025-02-27Annual report
- 8-K2025-02-27Current report (material event)
- 8-K2025-02-21Current report (material event)
- 8-K2025-01-14Current report (material event)
- 8-K2024-12-09Current report (material event)
- SCHEDULE 13G/A2024-12-06SCHEDULE 13G/A
- 8-K2024-12-02Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.